In our research,* we found that almost two-thirds of people agreed that if they knew a product was packaged in materials that fought pathogens like COVID-19, Norovirus and MRSA, they would definitely choose to buy it over similar products.
Organisations in the packaging industry are looking to address antiviral technology and recognise it as a way to gain a competitive edge.
What’s interesting is that this solution has always been available at James Cropper. For many years, PaperGard™, our range of bespoke papers with antiviral and antibacterial properties have been used in the medical industry. Only now is it attracting broader attention with recent tests having proven the papers to be effective at reducing the presence of SARS-CoV-2, the virus that causes COVID-19, on the surface of paper.
(*scroll down to see full results)